Sõpruse pst, 10615, Tallinn, Estonia +372-55650441
  1. Home
  2. Blog
Add Blog Entry RSS

Announcements

No announcements yet

New blog posts

The Underground Hydrogen Rush: A Cheap Green Fuel or Just a Pipe Dream?
The Underground Hydrogen Rush: A Cheap Green Fuel or Just a Pipe Dream?

20 September, 2026 by Mehrdad Fathi

For most of the past century, the idea that...

The Virtual Biotech: When 37,000 AI Agents Go Drug Hunting
The Virtual Biotech: When 37,000 AI Agents Go Drug Hunting

19 September, 2026 by Mehrdad Fathi

Drug discovery has always been a numbers game....

Ancient Architects: How Bizarre Microbes Are Rewriting the Story of Complex Life
Ancient Architects: How Bizarre Microbes Are Rewriting the Story of Complex Life

18 September, 2026 by Mehrdad Fathi

When Emily Aguilar-Pine drove 2,500 kilometres...

View all blog entries →

Journals

 

 

Weather

Clouds

13°C

Clouds in Tallinn

Calendar of Events

Closest Events
All events on this day

Blog

A Virtual Cell That Predicts Your Cancer Treatment

A Virtual Cell That Predicts Your Cancer Treatment

AI drug prediction cancer treatment computational oncology personalized oncology proteomics TNBC triple-negative breast cancer

Posted on 13 September, 2026 by Mehrdad Fathi

One of the persistent frustrations in oncology is this: two patients with the same cancer diagnosis, the same staging, even the same tumor type, can respond completely differently to the same drug. For triple-negative breast cancer, that frustration is acute. TNBC lacks the hormone and HER2 receptors that most targeted therapies exploit, leaving clinicians with a narrower toolkit and fewer molecular handles to guide treatment decisions. A study published in Nature on September 9...
From Undruggable to Unstoppable: How Daraxonrasib Is Rewriting the RAS Story

From Undruggable to Unstoppable: How Daraxonrasib Is Rewriting the RAS Story

cancer treatment 2026 daraxonrasib FDA approval immunotherapy adjacent oncology pancreatic cancer Revolution Medicines targeted therapy

Posted on 9 September, 2026 by Mehrdad Fathi

For decades, RAS proteins occupied a peculiar position in oncology: among the most commonly mutated drivers of cancer, yet effectively out of reach for targeted therapy. That designation — “undruggable” — is now being dismantled at pace. Just one week after the US FDA granted approval to daraxonrasib (Rasonque) for advanced pancreatic cancer, new data published in the New England Journal of Medicine on September 2 show the same drug shrinking tumours in more than 30% of participants...
Cancer Cases Could Surge 67% Worldwide by 2050

Cancer Cases Could Surge 67% Worldwide by 2050

cancer incidence cancer prevention cancer statistics global oncology GLOBOCAN 2024 life sciences oncology public health WHO

Posted on 8 September, 2026 by Mehrdad Fathi

The numbers are stark. In 2024, nearly 21 million people were diagnosed with cancer globally, and 9.8 million died from the disease. Now cases will reach 34 million by 2050 — a 67% increase driven almost entirely by population growth and aging, before any changes in risk factor exposure are factored in. For anyone working at the intersection of oncology, public health, or life sciences, this report lands as both a warning and a challenge. The Scale and Its Drivers The findings are...
Immune Therapy Engineered Inside the Body Eases Multiple Sclerosis

Immune Therapy Engineered Inside the Body Eases Multiple Sclerosis

autoimmune disease B cell depletion cancer immunology CAR-T cell therapy immunotherapy in vivo gene therapy lentiviral vector multiple sclerosis translational medicine

Posted on 7 September, 2026 by Mehrdad Fathi

For years, CAR-T-cell therapy has operated on a straightforward but labour-intensive logic: extract T cells from a patient, engineer them in a laboratory to target a specific molecule, and reinfuse them. It works. It has transformed outcomes in blood cancers. But it is slow, expensive, and operationally demanding in ways that limit who can access it and where. A clinical trial published this week in The New England Journal of Medicine tests a different premise: what if the genetic...
Who Is Responsible When AI Helps to Write Science?

Who Is Responsible When AI Helps to Write Science?

AI authorship AI in research generative AI open science research integrity scholarly publishing

Posted on 2 September, 2026 by Mehrdad Fathi

Generative AI is now embedded in the daily workflow of research. It summarizes literature, drafts sections, sharpens arguments, and increasingly shapes the conceptual framing of papers. Yet publishing norms have not kept pace. The question that remains unanswered is not whether AI is being used — it clearly is — but who is accountable for what it produces. Authorship was never just a credit mechanism. It is an accountability structure: a signal to the community that a named scholar stands...
  • Page 2 / 8
  • 1
  • 2
  • 3
  • 4
  • 5

Event Categories

0 Conference 0 Symposium 4 Workshop

Past Events

Workshop on Artificial Intelligence Applications in Smart Cities
20 August, 2024
Workshop on Advanced Water Treatment Processes
10 July, 2024
Workshop On Solar System Simulations and Green Buildings
10 May, 2024
Workshop on Water Recycling Simulation and Modelling
15 March, 2024

Today In History

Here are some interesting facts ih history happened on 22 September.

  1. Nassau Hall opens at Princeton University
  2. Nathan Hale is executed as a spy by the British
  3. The US Post Office was established
  4. Origin of French Republican Era
  5. President Lincoln makes his Emancipation Proclamation speech
  6. 1st auto built in US (by Duryea brothers) runs in Springfield
  7. Italo Marchiony granted a patent for the ice cream cone
  8. Ice Cream Cone patented
  9. Fred 'Bonehead' Merkle misses 2nd base costing NY Giants the pennant
  10. Yank Ben Paschal hits 2 inside-the-park-homers
  11. Yanks Earle Coombs hits 3 triples
  12. Famous "Long count" fight (Dempsey loses boxing title to Tunney)
  13. Boulogne reoccupied by Allies
  14. Stan Musial goes 5 for 5 off 5 different pitchers
  15. Mali gains independence from France (National Day)
  16. The Man from UNCLE premiers
  17. Zond 5 completes flight
  18. War between Iran & Iraq begins
  19. 2nd regular-season National Football League player strike begins

Menu

About TULTECH

TULTECH (Talent under Liberty in Technology) is a non-profit organization dedicated to advancing education, research, knowledge, and responsible technological innovation for the benefit of society. Through research, academic publishing, educational activities, events, and technology development, we connect researchers, educators, students, and communities to share knowledge and create practical solutions to social, environmental, and technological challenges.

Mission

Our mission is to advance education, research, knowledge, and technological innovation for the benefit of society. Through research, publications, educational activities, events, and open technological solutions, TULTECH promotes accessible learning, interdisciplinary collaboration, social and environmental responsibility, and the responsible use of technology to create positive impact in communities.

Vision

TULTECH envisions a globally connected society where education, research, and technology are accessible and used responsibly to address social, environmental, and technological challenges. We aspire to contribute to a more inclusive, sustainable, knowledgeable, and innovative future.

 

Talent under Liberty in Technology (TULTECH):  EE472200221072318428